KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quest Diagnostics (DGX) Cash from Investing Activities (2016 - 2025)

Historic Cash from Investing Activities for Quest Diagnostics (DGX) over the last 17 years, with Q3 2025 value amounting to -$201.0 million.

  • Quest Diagnostics' Cash from Investing Activities rose 8769.14% to -$201.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$942.0 million, marking a year-over-year increase of 5638.89%. This contributed to the annual value of -$2.5 billion for FY2024, which is 14015.08% down from last year.
  • Latest data reveals that Quest Diagnostics reported Cash from Investing Activities of -$201.0 million as of Q3 2025, which was up 8769.14% from -$124.0 million recorded in Q2 2025.
  • Quest Diagnostics' 5-year Cash from Investing Activities high stood at $437.0 million for Q2 2021, and its period low was -$1.6 billion during Q3 2024.
  • For the 5-year period, Quest Diagnostics' Cash from Investing Activities averaged around -$240.6 million, with its median value being -$158.0 million (2023).
  • As far as peak fluctuations go, Quest Diagnostics' Cash from Investing Activities surged by 31317.07% in 2021, and later plummeted by 142616.82% in 2024.
  • Over the past 5 years, Quest Diagnostics' Cash from Investing Activities (Quarter) stood at -$227.0 million in 2021, then grew by 23.35% to -$174.0 million in 2022, then surged by 34.48% to -$114.0 million in 2023, then crashed by 340.35% to -$502.0 million in 2024, then soared by 59.96% to -$201.0 million in 2025.
  • Its Cash from Investing Activities stands at -$201.0 million for Q3 2025, versus -$124.0 million for Q2 2025 and -$115.0 million for Q1 2025.